Included Seoul national hospital,10sites
Seoul, South Korea
NCT Number: NCT03489837
A randomized, double-blind, multicenter, active-controlled phase III study to evaluate the efficacy and safety of Levotuss CR tab. in comparison with Levotuss syrup in patients with cough due to acute or chronic bronchitis
Looking for future studies?
Notify Me19 year–75 year
All sexes
Interventional
Phase 3
Seoul, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral taken
Time frame: 6 hours
Hyundai Pharm
Industry
A Randomized, Double-blind, Multicenter, Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04069312
Bronchial Diseases, Bronchitis
Birmingham, Alabama, United States
View Trial DetailsNCT05843669
Bronchial Diseases, Bronchitis
Charlotte, North Carolina, United States
View Trial DetailsNCT00683722
Bronchial Diseases, Bronchitis
Los Angeles, California, United States
View Trial Details